Page 3 - போஸ்டர் ப்ரெஸெஂடேஶந்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from போஸ்டர் ப்ரெஸெஂடேஶந்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In போஸ்டர் ப்ரெஸெஂடேஶந்ஸ் Today - Breaking & Trending Today

Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy


Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer s Disease, Insomnia and Epilepsy
Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimer s disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome
News provided by
Share this article
Share this article
WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company s deep neurology pipeline and portfolio, including Alzheimer s disease, insomnia and epilepsy, will be presented at the 73
rd Annual Meeting of the American Academy of Neurology (AAN), taking place virtually from April 17-22, 2021. ....

United States , New Jersey , North Carolina , Gary Zammit , Shau Yu Lynch , Alzheimers Dement , Ryan Husni , Genevieve Meier , Carmen Castrillo Viguera , Craig Chepke , Ivan Cheung , Chris Vancheri , Michael Irizarry , Russell Rosenberg , Rakeh Jain , Rohit Shankar , National Institute On , Biogen Inc , Prnewswire Eisai Inc , European Union , Us Drug Enforcement Administration , Eisai Tsukuba Research Laboratories , Meeting Of The American Academy Neurology , National Institutes Of Health , Epilepsy Foundation , Drug Administration ,

UltraViolet Devices, Inc.: University of Siena Researchers Demonstrate Rapid UV Disinfection of Operating Rooms Between Surgeries


(0)
Italian Team Led by Dr. Gabriele Messina To Share Novel Operating Room Research Using the UVDI-360 Room Sanitizer at SHEA 2021
UltraViolet Devices, Inc. (UVDI), a global leader in Ultraviolet Air and Surface disinfection, announced new research demonstrating the UVDI-360 Room Sanitizer s rapid disinfection of operating rooms between surgical procedures will be presented at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference, taking place April 13-16, 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005184/en/
In the University of Siena research, the UVDI-360 Room Sanitizer effectively inactivated germs in operating rooms in six minutes. (Photo: Business Wire) ....

United States , Kostenloser Wertpapierhandel , Gabriele Messina , Peter Veloz , Professor Of Public Health , University Of Siena , Society For Healthcare Epidemiology Of America , Italian Team Led , Devices Inc , Violet Devices , Ultraviolet Air , Healthcare Epidemiology , Spring Conference , Business Wire , Public Health , Rugani Hospital Monteriggioni , Poster Abstract , Hospital Theatre , Poster Presentations , Chief Executive Officer , Ultraviolet Devices , United Statesa , Healthcare Associated Infections , Minority Business Enterprise , ஒன்றுபட்டது மாநிலங்களில் , கேப்ரியல் மெசினா ,

Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting


Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
SEATTLE, WA
/ ACCESSWIRE / April 9, 2021 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR
TM and ADAPTIR-FLEX
TM platform technologies, today announced that it will present two new posters at the American Association for Cancer Research Virtual Annual Meeting, to be held in two virtual sessions - Saturday, April 10
th to Thursday, April 15
th, 2021 and Monday, May 17
th to Friday, May 21
st, 2021.
Title: APVO603:
A Dual 4-1BB and OX40 bispecific approach utilizing ADAPTIR technology designed to deliver a conditional T cell/NK response against solid tumors ....

United States , Exchange Commission , Aptevo Therapeutics Inc , Aptevo Therapeutics , American Association , Cancer Research Virtual Annual Meeting , Poster Presentations , Virtual Poster Hall , Monday June , Private Securities Litigation Reform Act , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , அமெரிக்கன் சங்கம் , புற்றுநோய் ஆராய்ச்சி மெய்நிகர் ஆண்டு சந்தித்தல் , போஸ்டர் ப்ரெஸெஂடேஶந்ஸ் , மெய்நிகர் போஸ்டர் மண்டபம் , திங்கட்கிழமை ஜூன் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஆண்டு அறிக்கை ,